Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9051
CALL
Dorian LPG
LPG
$2.09B
| $397K | ﹤0.01% |
26,100
+15,600
| +149% | +$247K |
|
9052
CALL
Ring Energy
REI
$362M
| $397K | ﹤0.01% |
149,400
+35,000
| +31% | +$145K |
|
|
SFYX
9053
DELISTED
SoFi Next 500 ETF
SFYX
| $397K | ﹤0.01% |
37,064
+7,391
| +25% | +$88.9K |
|
9054
PUT
Titan Machinery
TITN
$428M
| $397K | ﹤0.01% |
17,700
-7,600
| -30% | -$189K |
|
9055
CALL
ProShares Ultra Financials
UYG
$844M
| $397K | ﹤0.01% |
9,200
+1,700
| +23% | +$88.5K |
|
9056
CALL
NewtekOne
NEWT
$372M
| $396K | ﹤0.01% |
20,900
-13,200
| -39% | -$317K |
|
9057
Vitamin Cottage Natural Grocers
NGVC
$633M
| $396K | ﹤0.01% |
24,872
-22,006
| -47% | -$409K |
|
9058
CALL
Global X SuperDividend US ETF
DIV
$784M
| $395K | ﹤0.01% |
20,300
+1,800
| +10% | +$36.9K |
|
9059
PUT
Hyliion Holdings
HYLN
$723M
| $395K | ﹤0.01% |
122,800
-20,200
| -14% | -$70.8K |
|
9060
CALL
InvenTrust Properties
IVT
$2.61B
| $395K | ﹤0.01% |
15,300
-1,300
| -8% | -$38K |
|
9061
CALL
The Joint Corp
JYNT
$120M
| $395K | ﹤0.01% |
25,800
-12,900
| -33% | -$288K |
|
9062
Pearson
PSO
$9.72B
| $395K | ﹤0.01% |
42,827
-221,468
| -84% | -$2.14M |
|
9063
CALL
Stepan Co
SCL
$1.48B
| $395K | ﹤0.01% |
3,900
-4,400
| -53% | -$455K |
|
|
QED
9064
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
| $395K | ﹤0.01% |
19,122
-26,140
| -58% | -$557K |
|
9065
Fidelity Total Bond ETF
FBND
$27.3B
| $394K | ﹤0.01% |
+8,457
| New | +$403K |
|
|
FRGE
9066
DELISTED
Forge Global Holdings
FRGE
| $394K | ﹤0.01% |
2,522
+2,091
| +485% | +$561K |
|
9067
CALL
Grid Dynamics Holdings
GDYN
$619M
| $394K | ﹤0.01% |
23,400
-400
| -2% | -$6.54K |
|
|
GOOD
9068
PUT
Gladstone Commercial Corp
GOOD
$622M
| $394K | ﹤0.01% |
20,900
+11,400
| +120% | +$232K |
|
9069
Vor Biopharma
VOR
$1.36B
| $394K | ﹤0.01% |
3,969
+1,089
| +38% | +$111K |
|
|
QQQH
9070
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $394K | ﹤0.01% |
10,250
-3,800
| -27% | -$168K |
|
|
AVDL
9071
DELISTED
Avadel Pharmaceuticals
AVDL
| $393K | ﹤0.01% |
161,062
+74,365
| +86% | +$305K |
|
9072
PUT
Banco Macro
BMA
$5.08B
| $393K | ﹤0.01% |
35,100
-18,100
| -34% | -$269K |
|
9073
CALL
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $393K | ﹤0.01% |
+4,700
| New | +$431K |
|
9074
Nuvectis Pharma
NVCT
$622M
| $393K | ﹤0.01% |
+35,069
| New | +$434K |
|
9075
PUT
Palomar
PLMR
$3.28B
| $393K | ﹤0.01% |
6,100
+200
| +3% | +$12.1K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.